METHOD FOR PREDICTING RISK OF ATHEROSCLEROTIC CARDIO-CEREBROVASCULAR DISEASES BY USING BLOOD CELL MUTANT INFORMATION

The present invention relates to a method for providing information about the risk of atherosclerotic cardio-cerebrovascular diseases. The method according to the present invention enables early and effective selection of a high-risk group of atherosclerotic cardio-cerebrovascular diseases through a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KIM, Su Gyeong, IM, Ho Gune, IM, Ji Woo, CHOI, Su Yeon, SUN, Choong Hyun, SONG, Han
Format:	Patent
Sprache:	eng ; fre ; kor
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a method for providing information about the risk of atherosclerotic cardio-cerebrovascular diseases. The method according to the present invention enables early and effective selection of a high-risk group of atherosclerotic cardio-cerebrovascular diseases through a combination of the risks of the presence of blood cell mutants and an LDL-cholesterol index, which are obtained from a biological sample isolated from a subject. Therefore, the method can maximize atherosclerotic cardio-cerebrovascular disease prevention effects. La présente invention concerne un procédé pour fournir des informations concernant le risque de maladies cardiovasculaires athérosclérotiques. Le procédé selon la présente invention permet une sélection précoce et efficace d'un groupe à haut risque de maladies cardio-cérébrovasculaires athérosclérotiques par une combinaison des risques de la présence de mutants des cellules sanguines et d'un indice de cholestérol LDL, ceux-ci étant obtenus à partir d'un échantillon biologique isolé chez un sujet. Par conséquent, le procédé peut maximiser les effets de prévention des maladies cardio-cérébrovasculaires athérosclérotiques. 본 발명은 죽상동맥경화성 심뇌혈관질환의 위험도에 대한 정보 제공 방법에 관한 것이다. 본 발명에 따른 방법은 대상으로부터 분리된 생물학적 시료로부터 얻은 혈액세포 돌연변이의 존재 여부 및 LDL-콜레스테롤 지표에 대한 위험도의 조합으로 죽상동맥경화성 심뇌혈관질환의 고위험군을 조기에 유효하게 선별할 수 있게 한다. 따라서, 이러한 방법은 죽상동맥경화성 심뇌혈관질환의 예방효과를 극대화시킬 수 있다.